Main > ONCOLOGY (**) > Lymphoma>NHL>T-Cell>CTCL R *** > Treatment > Co: JP. E. Denileukin Diftitox Inj.

---

Co: JP. E. Denileukin Diftitox Inj.'s subsections

(*) USA Accelerated OK: 1999
(*) USA Full OK: 2008. 10.16
Company
Diphtheria Toxin-IL2 Fusion Protein
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2006. 10.31
Patent>USA Expiration: 2010. 03.02
TradeMark
TradeMark Web-Site

Co: JP. E. Denileukin Diftitox Inj.'s products
This section has no products